AstraZeneca Shares to Start Trading in US After Listing Upgrade
Why it matters
AstraZeneca's shares will begin trading on the New York Stock Exchange, replacing its existing American Depositary Receipts on Nasdaq, as part of a listing upgrade.
Expected market reaction
Market impact analysis based on bullish sentiment with 80% confidence.
Evidence trail
Evidence
Source
Bloomberg
Claim
AstraZeneca Shares to Start Trading in US After Listing Upgrade
AI inference
Bullish · 80%
Generated
2026-02-02 07:46
AI provenance
Technical identifiers
- Provider tag
- groq-llama-3.1-8b-instant
- Analysis version
- groq-llama-3.1-8b-instant
- Article id
- 40189
Original source
Shares of AstraZeneca Plc, the UK’s biggest drugmaker, will start trading on the New York Stock Exchange on Monday following a listing upgrade to replace its American Depositary Receipts that were on Nasdaq.
Read the full article on Bloomberg
Original article published by Bloomberg on February 2, 2026. Analysis and insights provided by AnalystMarkets AI.